Tag: supplement

Cheyenne, Wyoming, July 23, 2026 (GLOBE NEWSWIRE) -- Core Axis, a health brand founded by MC Bio-Logic LLC, announces the upcoming launch of its daily supplement protocol developed with Hashimoto's thyroiditis in mind. Hashimoto's thyroiditis is the autoimmune condition that affects an estimated five million Americans and remains the leading cause of hypothyroidism in the United States. Designed using evidence-based ingredient selection and clinically relevant dosages, the new protocol addresses nutritional factors relevant to individuals with autoimmune thyroid conditions rather than providing general thyroid support. The company is now inviting individuals to join its early access waitlist ahead of the official product launch.

BEVERLY, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- ATN International, Inc. (“ATN” or the “Company”) (Nasdaq: ATNI), a provider of digital infrastructure and communications services, announced today that it will release its second quarter 2026 financial results on Wednesday, August 5, 2026, after market close. The Company will host a conference call to discuss the results starting at 11:00 a.m. Eastern time on Thursday, August 6, 2026.

HOUSTON, July 22, 2026 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) ("Crown Castle") today reported results for the second quarter ended June 30, 2026, and updated its full year 2026 Outlook, as reflected in the table below.

New report provides an educational framework for reviewing testosterone booster supplements, ingredient transparency, supplement labels, consumer safety considerations, and responsible product research.

Announcing BurnTide Gummies, a natural supplement designed to complement healthy weight loss. Learn how Burn Tide fits into a balanced diet, active lifestyle, and daily wellness routine.

HAMBURG, Germany and MUNICH, June 26, 2026 (GLOBE NEWSWIRE) -- XCHG Limited ("XCharge" or the "Company") (Nasdaq: XCH), an integrated EV charging and energy solutions company, today announced that it has entered into a securities purchase agreement with a single global institutional investor for the purchase and sale of 7,000,000 of the Company’s American depositary shares (the “ADSs”) in a registered direct offering. The gross proceeds from the offering are expected to be approximately $4.375 million, before deducting placement agent commissions and other offering expenses.